Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meldonium for Fatigue in Metastatic Renal Cell Carcinoma
NCT06648902Phase 2Completed
- Start
- Feb 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of meldonium in fatigue. Started Feb 2022; status: completed.
02
Drugs
meldonium
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT06648902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06648902.